Cargando…

Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma

BACKGROUND: The conception that serological hepatitis markers determined surgical prognosis of hepatocellular carcinoma (HCC) associated with hepatitis B (HBV) or hepatitis C (HCV) has been well defined. However, little is known about the relationship between surgical outcomes and serological hepati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Xiu-Tao, Shi, Ying-Hong, Zhou, Jian, Peng, Yuan-Fei, Liu, Wei-Ren, Shi, Guo-Ming, Gao, Qiang, Wang, Xiao-Ying, Song, Kang, Fan, Jia, Ding, Zhen-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445430/ https://www.ncbi.nlm.nih.gov/pubmed/28559922 http://dx.doi.org/10.1186/s13027-017-0137-6

Ejemplares similares

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2019)

Autophagy activation contributes to glutathione transferase Mu 1-mediated chemoresistance in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2018)

Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis
por: Tao, Chen-Yang, et al.
Publicado: (2018)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
por: Zhao, Yang, et al.
Publicado: (2019)

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
por: Shaohua, Li, et al.
Publicado: (2015)

Dual Role of Hepatic Macrophages in the Establishment of the Echinococcus multilocularis Metacestode in Mice
por: Wang, Hui, et al.
Publicado: (2021)

Probing the Hepatic Progenitor Cell in Human Hepatocellular Carcinoma
por: Jia, Shu-Qin, et al.
Publicado: (2013)

The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
por: Yan, Long, et al.
Publicado: (2015)

Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma
por: Hu, Hao, et al.
Publicado: (2016)

High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection
por: Zhang, Yingyu, et al.
Publicado: (2018)

Mutations in hepatitis B virus polymerase are associated with the postoperative survival of hepatocellular carcinoma patients
por: Yin, Fei, et al.
Publicado: (2017)

Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study
por: Xu, Baiguo, et al.
Publicado: (2022)

Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score–Matched Study and Meta-Analysis
por: Chen, Jia-Feng, et al.
Publicado: (2021)

Serum Prealbumin is Negatively Associated with Survival in Hepatocellular Carcinoma Patients after Hepatic Resection
por: Liao, Ying-Yang, et al.
Publicado: (2019)

Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age
por: Zi, Jun, et al.
Publicado: (2023)

Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy
por: Peng, Yuan-Fei, et al.
Publicado: (2013)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics
por: Wang, Yang, et al.
Publicado: (2021)

Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma
por: Wang, Zhi-Chao, et al.
Publicado: (2013)

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies
por: Zhou, Yanming, et al.
Publicado: (2011)

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C
por: Yeh, Ming-Lun, et al.
Publicado: (2018)

In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus
por: Zhang, Xiu-Ping, et al.
Publicado: (2019)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Sha, Meng, et al.
Publicado: (2021)

A single hepatic mass with two tales: hepatic tuberculosis and hepatocellular carcinoma
por: Koh, Yi De Ian, et al.
Publicado: (2023)

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
por: Shen, Yu-Chuan, et al.
Publicado: (2022)

Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma
por: Devbhandari, Ranjan Prasad, et al.
Publicado: (2011)

MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection
por: Zhu, Hai-Tao, et al.
Publicado: (2012)

Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma
por: Xu, Xin, et al.
Publicado: (2022)

Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth
por: Yang, Hua, et al.
Publicado: (2015)

A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2018)

Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model
por: Shen, Fei-Fei, et al.
Publicado: (2018)

Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy
por: Yang, Fu-Qiang, et al.
Publicado: (2017)

The interaction of ammonia and manganese in abnormal metabolism of minimal hepatic encephalopathy: A comparison metabolomics study
por: Liu, Xue-Fei, et al.
Publicado: (2023)

Anti-hepatitis, antioxidant activities and bioactive compounds of Dracocephalum heterophyllum extracts
por: Shi, Qiang-Qiang, et al.
Publicado: (2016)

Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
por: Liu, Qisha, et al.
Publicado: (2019)

Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges
por: Huang, Ao, et al.
Publicado: (2022)

Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma
por: Zhang, Rui-Jun, et al.
Publicado: (2023)

Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
por: Lu, Qiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_859cvm5258mhtrkd6nm06ddmfb